CRDL Stock Analysis: Buy, Sell, or Hold?
CRDL - Cardiol Therapeutics Inc. Class A Common Shares
$1.12
-0.03 (-2.61%)
▼
5d:
+1.82%
30d:
-35.26%
90d:
-3.03%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 12, 2026
18d
Get Alerted When CRDL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRDL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRDL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRDL is currently trading at $1.12, which is considered oversold relative to its 30-day fair value range of $1.17 to $1.79.
Technical Outlook: Technically, CRDL is in a uptrend. Immediate support is located at $1.08, while resistance sits at $1.29.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.58 (+666.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRDL is in a uptrend. Immediate support is located at $1.08, while resistance sits at $1.29.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.58 (+666.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.17 -
$1.79
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 666.4% below Wall St target ($8.58)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.17 -
$1.79
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.08
Resistance Level
$1.29
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.43
Wall Street Target
$8.58
(+666.4%)
Share & Embed Analysis
Last updated: October 24, 2026 3:53 AM ET
Data refreshes hourly during market hours. Next update: 4:53 AM
Data refreshes hourly during market hours. Next update: 4:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 56 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 47 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 38 SELL |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 54 HOLD |
